Top Food and Drug Cases 2020 and Cases to Watch 2021: GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.

Every year, the Food and Drug Law Institute (FDLI) publishes a compendium of the Top Food and Drug Cases from the previous year, as well as Cases to Watch, in conjunction with its popular Annual Conference.  In this year’s publication, Sara Koblitz explains an important Federal Circuit decision in the “skinny label” or “carveout” provisions of Hatch-Waxman in the context of pharmaceutical patent litigation.